Journal article
Glycine amidinotransferase (GATM), renal Fanconi syndrome, and kidney failure
- Abstract:
- Background For many patients with kidney failure, the cause and underlying defect remain unknown. Here, we describe a novel mechanism of a genetic order characterized by renal Fanconi syndrome and kidney failure.Methods We clinically and genetically characterized members of five families with autosomal dominant renal Fanconi syndrome and kidney failure. We performed genome-wide linkage analysis, sequencing, and expression studies in kidney biopsy specimens and renal cells along with knockout mouse studies and evaluations of mitochondrial morphology and function. Structural studies examined the effects of recognized mutations.Results The renal disease in these patients resulted from monoallelic mutations in the gene encoding glycine amidinotransferase (GATM), a renal proximal tubular enzyme in the creatine biosynthetic pathway that is otherwise associated with a recessive disorder of creatine deficiency. In silico analysis showed that the particular GATM mutations, identified in 28 members of the five families, create an additional interaction interface within the GATM protein and likely cause the linear aggregation of GATM observed in patient biopsy specimens and cultured proximal tubule cells. GATM aggregates-containing mitochondria were elongated and associated with increased ROS production, activation of the NLRP3 inflammasome, enhanced expression of the profibrotic cytokine IL-18, and increased cell death.Conclusions In this novel genetic disorder, fully penetrant heterozygous missense mutations in GATM trigger intramitochondrial fibrillary deposition of GATM and lead to elongated and abnormal mitochondria. We speculate that this renal proximal tubular mitochondrial pathology initiates a response from the inflammasome, with subsequent development of kidney fibrosis.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 5.7MB, Terms of use)
-
- Publisher copy:
- 10.1681/asn.2017111179
Authors
+ David and Elaine Potter Charitable Foundation
More from this funder
- Funding agency for:
- Kleta, R
- Grant:
- 2012-305608
+ Moorhead Trust
More from this funder
- Funding agency for:
- Bockenhauer, D
- Kleta, R
- Grant:
- 2012-305608
- 2012-305608
+ Kids Kidney Research
More from this funder
- Funding agency for:
- Bockenhauer, D
- Kleta, R
- Grant:
- 2012-305608
- 2012-305608
+ European Union
More from this funder
- Funding agency for:
- Bockenhauer, D
- Unwin, RJ
- Kleta, R
- Grant:
- 2012-305608
- 2012-305608
- 2012-305608
+ Lowe Syndrome Trust
More from this funder
- Funding agency for:
- Bockenhauer, D
- Unwin, RJ
- Kleta, R
- Grant:
- 2012-305608
- 2012-305608
- 2012-305608
- Publisher:
- American Society of Nephrology
- Journal:
- Journal of the American Society of Nephrology More from this journal
- Volume:
- 29
- Issue:
- 7
- Pages:
- 1849-1858
- Publication date:
- 2018-04-13
- Acceptance date:
- 2018-02-27
- DOI:
- EISSN:
-
1533-3450
- ISSN:
-
1046-6673
- Pmid:
-
29654216
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:843430
- UUID:
-
uuid:57e146d1-bfee-48e7-b94e-be3c50aaad2d
- Local pid:
-
pubs:843430
- Source identifiers:
-
843430
- Deposit date:
-
2018-05-03
Terms of use
- Copyright holder:
- © 2018 by the American Society of Nephrology
- Copyright date:
- 2018
- Notes:
- This is the author accepted manuscript following peer review version of the article. The final version is available online from American Society of Nephrology at: 10.1681/asn.2017111179
If you are the owner of this record, you can report an update to it here: Report update to this record